Petaluma biotech startup Oculus raises $1.75 million

<p>Petaluma biotech startup Oculus Innovative Sciences has raised $1.75 million from institutional investors in a private financing deal, the company said Monday. </p><p>Oculus, which makes infection-fighting products, will use the funding to expand sales in the United States, Europe, Asia, Mexico, the Middle East and other markets, it said. </p><p>The investors also have the right to purchase an additional 2.6 million shares at various prices. </p><p>The deal follows a $3 million investment in Oculus last month from VetCure Inc., which gained rights to distribute Oculus’ Vetericyn Wound Care for animals in the U.S. </p><p>Oculus is seeking a partner to fund clinical trials aimed at getting its Microcyn liquid approved as a drug in the U.S. It has about 57 employees, including 36 at its Petaluma headquarters.</p>